Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

Hormel joins Tyson Foods, JBS in removing drug banned by China from hog supply

Published 02/18/2020, 09:39 PM
© Reuters. FILE PHOTO: The company logo for Hormel Foods is displayed on a screen on the floor at the NYSE in New York

By Tom Polansek

CHICAGO (Reuters) - Spam-maker Hormel Foods Corp (N:HRL) is eliminating a growth drug banned by China from its hog supply, the company said on Tuesday, joining rivals that are seeking to increase meat sales to Chinese buyers grappling with a pork shortage.

Hormel will not accept any hogs that have been fed or exposed to the drug ractopamine after April 1, the company said in a statement.

Tyson Foods Inc (N:TSN) and JBS USA said last year they would remove the drug from their supply chains. The companies' moves ramped up the competition to profit from increased demand in China, the world's largest pork consumer, where an outbreak of the fatal pig disease African swine fever has decimated herds.

"We have been actively monitoring the changing global market dynamics for several years and believe this decision will further position us to meet growing international demand," Hormel said.

Ractopamine is used in some countries to raise leaner pigs, but China does not allow its use or tolerate residues in imported meat. The European Union also bans ractopamine.

Elanco Animal Health Inc (N:ELAN) manufactures Paylean, its brand name for a ractopamine feed ingredient.

"We’re disappointed in any decision that would take safe, proven technology out of the hands of farmers," Elanco said.

China is expected to buy more U.S. pork after agreeing to significantly increase imports of American farm goods as part of an interim trade deal reached last month with Washington. Beijing said it will grant exemptions on retaliatory tariffs imposed against 696 U.S. goods, including pork, that had hampered American exports.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

China agreed as part of the trade deal to work with U.S. experts to "conduct a risk assessment for ractopamine in cattle and swine as soon as possible without undue delay," according to the agreement. It said the countries will establish a joint working group to discuss the steps to be taken based on the results of the assessment.

Chinese pork prices last week neared a record set in 2019 after measures to battle the coronavirus epidemic disrupted the transportation of pigs and the restart of slaughtering plants, crimping already tight supplies.

Hormel, which sells ham, pork tenderloin and other meat products, does not slaughter hogs itself. Instead, it partners with third-party suppliers that process the animals for Hormel's raw materials.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.